Professor of Psychiatry and a Neuroscientist at Yale University.Focuses on technology-enabled, web-delivered neurocognitive training programs that harness the brain’s neuro-plastic potential to improve health and education outcomes. Key role in launch of digital neurotherapeutics in the 1990’s, demonstrating that digital neurotherapies can improve cognitive function, normalize task-related brain activation and improve employment outcomes in people with schizophrenia. Has since developed programs that can reduce clinical symptoms and improve cognition in children with ADHD and adults with depression. Founded C8Sciences to bring these programs more fully into the world. C8’s program for elementary school children improves executive cognitive skills essential for learning, and has proved a powerful tool to mitigate negative effects of childhood poverty on development of cognitive function and associated academic and life outcomes. Used by 35,000 children across the U.S. and every continent in the world. Children in classes using the C8 program had 4x increase in percentages meeting state proficiency standards in math and reading.NIMH Career Scientist x 15 years and NIH Director’s Award for “high innovation, high impact, paradigm changing medical research.” Download full CV and list of grants and publications: https://medicine.yale.edu/psychiatry/profile/bruce_wexler/. 4 ongoing clinical trials of C8 digital neurotherapies: